Announcements
Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Takara, Clontech, and Cellartis brands. To keep you up to date with the latest happenings at Takara Bio USA, we have compiled our recent announcements and press releases below.
Takara Bio’s first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery
Date: February 5, 2024
Categories: Press release
Takara Bio USA, Inc. announced plans to launch two critical solutions for oncology research. These automated single-cell total RNA-seq and DNA-seq library preparation kits will provide high sample and cell throughput, less hands-on time, and the ability to capture more information than other available technologies.
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics’ NGS library enrichment patent
Date: December 11, 2023
Categories: Press release
Takara Bio USA, Inc. today announced that it has once again prevailed in its second patent dispute with Jumpcode Genomics, Inc.
Takara Bio enters into a license agreement of RetroNectin with Fondazione Telethon ETS
Date: September 25, 2023
Categories: Announcement
Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS, Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin.
Automation of Takara Bio’s chemistries on Eppendorf’s automated pipetting systems for significantly higher efficiency
Date: August 28, 2023
Categories: Announcement
Takara Bio Inc. (Takara Bio) and Eppendorf SE, two renowned leaders in the life science industry, are pleased to announce their collaboration through a strategic co-marketing agreement. This partnership aims at jointly developing cutting-edge solutions to automate Takara Bio’s chemistries on Eppendorf epMotion® automation platforms.
Takara Bio is committed to the fight against antimicrobial resistance
Date: December 30, 2022
Categories: Announcement
Access a USA Today article describing solutions that combat the dangerous growth of antimicrobial resistance.
Takara Bio USA, Inc. and BioExcel Diagnostics partner for development of wide-coverage infectious disease detection panels
Date: October 17, 2022
Categories: Press release
BioExcel Diagnostics has partnered with Takara Bio, USA, Inc. to develop and validate wide-coverage infectious disease detection panels using the SmartChip Real-Time PCR System.
Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections
Date: September 6, 2022
Takara Bio Europe (TBE) announced a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Takara Bio, Inc expands GMP facility to accommodate a variety of modalities and strengthen supply chain
Date: March 26, 2022
In response to rapidly increasing demands for CDMO services, including manufacturing of gene therapy drugs and vaccines, the new GMP facility expanded its manufacturing capacity. We plan full operation by 2023.
Takara Bio USA wins EU opposition hearing on its foundational NGS library enrichment patent
Date: February 15, 2022
Categories: Press release
Learn how TBUSA’s granted European patent EP 3105325 was upheld by the European Patent Office which confirmed it's validity after an opposition claim was made against it.
Takara Bio USA, Inc. launches automated, full-length single-cell RNA-seq solution for enhanced biomarker discovery
Date: October 18, 2021
Categories: Announcement
Our complete, automated solution for biomarker discovery enables full-length transcriptome profiling on over 1,500 single cells simultaneously.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.